BRIEF published on 08/15/2026 at 00:55, 3 months 5 days ago Revive Therapeutics Grants 15.5 Million Stock Options Stock Options Life Sciences Biodefense Pandemic Preparedness Revive Therapeutics
PRESS RELEASE published on 08/15/2026 at 00:50, 3 months 5 days ago Revive Therapeutics Reports Grant of Options Revive Therapeutics Ltd. authorized the grant of 15,500,000 incentive stock options to key team members. The options aim to drive performance and incentivize excellence in advancing corporate objectives Stock Options Incentive Pandemic Preparedness Revive Therapeutics Ltd. Biodefence
BRIEF published on 08/12/2026 at 14:00, 3 months 8 days ago Revive Therapeutics annonce des résultats d'étude positifs sur la bucillamine pour l'exposition aux agents neurotoxiques Biodefense Bucillamine Revive Therapeutics Recherche Sur Les Agents Neurotoxiques Étude Du DRDC
BRIEF published on 08/12/2026 at 14:00, 3 months 8 days ago Revive Therapeutics Announce Positive Study Results on Bucillamine for Nerve-Agent Exposure Bucillamine Revive Therapeutics Nerve-agent Research DRDC Study Biodefence
PRESS RELEASE published on 08/12/2026 at 13:55, 3 months 8 days ago Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study Revive Therapeutics announces positive results from DRDC research study on bucillamine in nerve-agent exposure model, showing preservation of GABA receptors. Further studies planned Bucillamine Revive Therapeutics DRDC Research Study Nerve-agent Exposure GABA Receptors
BRIEF published on 07/16/2026 at 00:45, 4 months 4 days ago Revive Therapeutics finalise la première tranche de placements privés Placement Privé Sciences De La Vie Actions Et Bons De Souscription Initiative De Financement Revive Therapeutics
BRIEF published on 07/16/2026 at 00:45, 4 months 4 days ago Revive Therapeutics Completes First Tranche of Private Placement Private Placement Life Sciences Shares And Warrants Funding Initiative Revive Therapeutics
PRESS RELEASE published on 07/16/2026 at 00:40, 4 months 4 days ago Revive Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement Revive Therapeutics Ltd. closes the first tranche of non-brokered private placement, raising $246,920 for infectious diseases and medical countermeasures research and development Private Placement Research And Development Medical Countermeasures Infectious Diseases Revive Therapeutics Ltd.
BRIEF published on 06/26/2026 at 22:20, 4 months 23 days ago Revive Therapeutics propose un placement privé pour lever 1 million de dollars Investissement Actions Placement Privé Sciences De La Vie Revive Therapeutics
BRIEF published on 06/26/2026 at 22:20, 4 months 23 days ago Revive Therapeutics Proposes Private Placement to Raise $1 Million Private Placement Shares Life Sciences Investment Revive Therapeutics
Published on 11/20/2026 at 15:00, 5 hours 48 minutes ago Jaguar Health, Inc. Announces Reverse Stock Split
Published on 11/20/2026 at 14:50, 5 hours 58 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 6 hours 48 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 7 hours 18 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 7 hours 18 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 19:26, 1 hour 22 minutes ago EQS-Adhoc: TAKKT AG: TAKKT revises its 2026 full-year forecast following the cyberattack
Published on 11/20/2026 at 19:03, 1 hour 44 minutes ago EQS-Adhoc: Allgeier SE confirms rumors regarding sale process for the Evora Group
Published on 11/20/2026 at 18:18, 2 hours 29 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary figures for FY 2025/26: Order intake above previous year, free cash flow positive; EBIT below guidance due to additional project costs in the gH2 segment
Published on 11/20/2026 at 17:35, 3 hours 13 minutes ago Guangzhou Nansha: GBA's strategic pivot for Asia-Pacific trade
Published on 11/20/2026 at 18:34, 2 hours 13 minutes ago Déclaration hebdomadaire d'opérations effectuées du 16 au 20 novembre 2026
Published on 11/20/2026 at 18:34, 2 hours 13 minutes ago Disclosure of transactions in own shares from November 16 to November 20, 2026
Published on 11/20/2026 at 17:35, 3 hours 13 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 16 au 20 novembre 2026
Published on 11/20/2026 at 17:35, 3 hours 13 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 16 to November 20, 2026